Ionis Pharmaceuticals

top of page

Ionis Pharmaceuticals' CEO Brett Monia discusses the recent trial success of olezarsen in severe hypertriglyceridemia, the approval of Dawnzera in HAE, and more

He describes the significance of the olezarsen trial success in this patient population, and next steps. Plus, how Dawnzera might compete...

Sep 8

SF Healthcare Week: The CEO of Ionis talks about over 30 years of developing RNA therapies, and a new chapter as a commercial forward company

Brett Monia discusses the approval of TRYNGOLZA and an important data readout this year in severe hypertriglyceridemia. Plus, the...

Company News

Jan 15

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.

Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.

Learn more about Evaluate

bottom of page

Ionis Pharmaceuticals' CEO Brett Monia discusses the recent trial success of olezarsen in severe hypertriglyceridemia, the approval of Dawnzera in HAE, and more

SF Healthcare Week: The CEO of Ionis talks about over 30 years of developing RNA therapies, and a new chapter as a commercial forward company

Follow BiotechTV

Sponsors

Sponsor Spotlight